Literature DB >> 14744241

The integration of pharmacokinetics and pharmacodynamics: understanding dose-response.

Susan M Abdel-Rahman1, Ralph E Kauffman.   

Abstract

Pharmacokinetic (PK) and pharmacodynamic (PD) studies have proven to be powerful and instructive tools, particularly in elucidating important aspects of human pharmacology. Nevertheless, they remain imperfect tools in that they only allow researchers to indirectly extrapolate, through computational modeling, the dynamic processes of drug action. Furthermore, neither tool alone provides a complete nor necessarily relevant picture of drug action. This review explores the utility and applications of PK and PD in the study of drugs, provides examples of lessons learned from their application to studies of human pharmacology, points out some of their limitations, and advances the thesis that these tools ideally should be employed together in an integrated approach. As we continue to apply these tools across the continuum of age and disease, they provide a powerful means to enhance our understanding of drug action, drug interactions, and intrinsic host factors that influence pharmacologic response.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14744241     DOI: 10.1146/annurev.pharmtox.44.101802.121347

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  10 in total

Review 1.  Microfluidics for drug discovery and development: from target selection to product lifecycle management.

Authors:  Lifeng Kang; Bong Geun Chung; Robert Langer; Ali Khademhosseini
Journal:  Drug Discov Today       Date:  2007-11-26       Impact factor: 7.851

Review 2.  Integrated pharmacokinetics and pharmacodynamics in drug development.

Authors:  Jasper Dingemanse; Silke Appel-Dingemanse
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

3.  Effect of repetitive administration of Doxorubicin-containing liposomes on plasma pharmacokinetics and drug biodistribution in a rat brain tumor model.

Authors:  Robert D Arnold; Donald E Mager; Jeanine E Slack; Robert M Straubinger
Journal:  Clin Cancer Res       Date:  2005-12-15       Impact factor: 12.531

Review 4.  Pharmacology for the Audiologist.

Authors:  Tracy Offerdahl; Vallabhi Mishra
Journal:  Semin Hear       Date:  2019-04-26

5.  Prediction of Tumor-to-Plasma Ratios of Basic Compounds in Subcutaneous Xenograft Mouse Models.

Authors:  Prashant B Nigade; Jayasagar Gundu; K Sreedhara Pai; Kumar V S Nemmani
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-06       Impact factor: 2.441

6.  Correcting oral contraceptive pharmacokinetic alterations due to obesity: a randomized controlled trial.

Authors:  Alison B Edelman; Ganesh Cherala; Myrna Y Munar; Martha McInnis; Frank Z Stanczyk; Jeffrey T Jensen
Journal:  Contraception       Date:  2014-06-27       Impact factor: 3.375

7.  Membrane-stabilizing copolymers confer marked protection to dystrophic skeletal muscle in vivo.

Authors:  Evelyne M Houang; Karen J Haman; Antonio Filareto; Rita C Perlingeiro; Frank S Bates; Dawn A Lowe; Joseph M Metzger
Journal:  Mol Ther Methods Clin Dev       Date:  2015-11-11       Impact factor: 6.698

8.  ebTrack: an environmental bioinformatics system built upon ArrayTrack.

Authors:  Minjun Chen; Jackson Martin; Hong Fang; Sastry Isukapalli; Panos G Georgopoulos; William J Welsh; Weida Tong
Journal:  BMC Proc       Date:  2009-03-10

9.  Material basis of Chinese herbal formulas explored by combining pharmacokinetics with network pharmacology.

Authors:  Lixia Pei; Yuanwu Bao; Sheng Liu; Jin Zheng; Xiuping Chen
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

10.  Molecular mechanisms of detection and discrimination of dynamic signals.

Authors:  G Antunes; A C Roque; F M Simoes-de-Souza
Journal:  Sci Rep       Date:  2018-02-06       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.